RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Christopher Navara to Protein Conformation

Back to Details
This is a "connection" page, showing publications Christopher Navara has written about Protein Conformation.
Christopher Navara
Connection Strength
0.020
Protein Conformation
  1. Uckun FM, Mao C, Vassilev AO, Navara CS, Narla RK, Jan ST. A rationally designed anticancer drug targeting a unique binding cavity of tubulin. Bioorg Med Chem Lett. 2000 May 15; 10(10):1015-8.
    View in: PubMed
    Score: 0.010
  2. Ghosh S, Zheng Y, Jun X, Narla RK, Mahajan S, Navara C, Mao C, Sudbeck EA, Uckun FM. Alpha-cyano-beta-hydroxy-beta-methyl-N-[4-(trifluoromethoxy)phenyl] propenamide: an inhibitor of the epidermal growth factor receptor tyrosine kinase with potent cytotoxic activity against breast cancer cells. Clin Cancer Res. 1998 Nov; 4(11):2657-68.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support